Show simple item record

dc.contributor.authorWilliam Acree*
dc.date.accessioned2021-02-12T06:11:24Z
dc.date.available2021-02-12T06:11:24Z
dc.date.issued2012*
dc.date.submitted2019-10-03 07:51:48*
dc.identifier36351*
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/61066
dc.description.abstractModern drug design and testing involves experimental in vivo and in vitro measurement of the drug candidate's ADMET (adsorption, distribution, metabolism, elimination and toxicity) properties in the early stages of drug discovery. Only a small percentage of the proposed drug candidates receive government approval and reach the market place. Unfavorable pharmacokinetic properties, poor bioavailability and efficacy, low solubility, adverse side effects and toxicity concerns account for many of the drug failures encountered in the pharmaceutical industry. Authors from several countries have contributed chapters detailing regulatory policies, pharmaceutical concerns and clinical practices in their respective countries with the expectation that the open exchange of scientific results and ideas presented in this book will lead to improved pharmaceutical products.*
dc.languageEnglish*
dc.subjectRA1190-1270*
dc.subject.otherToxicology*
dc.subject.otherToxicology and Pharmaceutical Science*
dc.subject.otherToxinology*
dc.subject.otherPharmacology*
dc.subject.otherHealth Sciences*
dc.titleToxicity and Drug Testing*
dc.typebook
oapen.identifier.doi10.5772/1976*
oapen.relation.isPublishedBy78a36484-2c0c-47cb-ad67-2b9f5cd4a8f6*
oapen.relation.isbn9789535100041*
oapen.pages530*
oapen.edition1st Edition*


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record